Analysis of TGCA-LAML and GEO/ENA-AML datasets established a negative correlation between RBFOX2 expression and exon 23 skipping (Fig. 10e; Supplementary Fig. 7b, c). This evidence concerns the gene RBFOX2 and acute myeloid leukemia.